- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Novel Tissues covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (45), financial health (95), director (95) and company-foundation signals.
- Operating for 23+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2023 - filings look overdue.
- Profitable in FY 2023.
- Positive net worth.
- 2 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Novel Tissues
Novel Tissues is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U05190KA2003PTC032338). Business overview includes Manufacturing (Paper & Packaging Products), incorporated on July 30, 2003 (23+ years old), headquartered in Bangalore, Karnataka, India. The company is currently Active with Active Compliant compliance status.
- Location No.2, First Floor City Point13/7, Infantry Road, Bangalore, Karnataka - 570018
- Website noveltissues.com
Financial Performance of Novel Tissues
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Novel Tissues (2)
Charges of Novel Tissues
| Lender | Amount | Status |
|---|---|---|
|
Sidbi
Creation Date: 19 Mar 2025 |
2.00 cr | Open |
|
Sidbi
Creation Date: 28 Jun 2024 |
5.95 cr | Open |
|
Sidbi
Creation Date: 28 Jun 2024 |
2.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
| Manufacturing | - | 100 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
